Max Reinhardt
Net Worth

Last updated:

What is Max Reinhardt net worth?

The estimated net worth of Mr. Max Reinhardt is at least $10,587,153 as of 7 Jun 2023. He owns shares worth $736,178 as insider, has earned $5,600,175 from insider trading and has received compensation worth at least $4,250,800 in Pacira BioSciences, Inc..

What is the salary of Max Reinhardt?

Mr. Max Reinhardt salary is $850,160 per year as Pres of Rest of World in Pacira BioSciences, Inc..

How old is Max Reinhardt?

Mr. Max Reinhardt is 54 years old, born in 1971.

What stocks does Max Reinhardt currently own?

As insider, Mr. Max Reinhardt owns shares in one company:

Company Title Shares Price per share Total value
Pacira BioSciences, Inc. (PCRX) Pres of Rest of World 29,225 $25.19 $736,178

What does Pacira BioSciences, Inc. do?

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

PCRX logo
PCRX
Pacira BioSciences, Inc.
$25.19

Max Reinhardt insider trading

Pacira BioSciences, Inc.

Mr. Max Reinhardt has made 15 insider trades between 2020-2023, according to the Form 4 filled with the SEC. Most recently he sold 1,099 units of PCRX stock worth $41,614 on 7 Jun 2023.

The largest trade he's ever made was exercising 25,420 units of PCRX stock on 17 Sep 2020. As of 7 Jun 2023 he still owns at least 29,225 units of PCRX stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 1,099 $37.87 $41,614
Sale
Common Stock 1,054 $38.99 $41,097
Sale
Common Stock 1,380 $58 $80,040
Sale
Common Stock 2,433 $62 $150,846
Sale
Common Stock 2,817 $61.37 $172,891
Sale
Common Stock 9,824 $73.25 $719,647
Option
Common Stock 12,500 $42.54 $531,750
Option
Stock Option (Right to Buy) 12,500 $42.54 $531,750
Option
Stock Option (Right to Buy) 12,500 $42.54 $531,750
Option
Common Stock 12,500 $42.54 $531,750
Option
Stock Option (Right to Buy) 12,500 $42.54 $531,750
Option
Stock Option (Right to Buy) 12,500 $42.54 $531,750
Sale
Common Stock 9,764 $73.99 $722,438
Sale
Common Stock 9,321 $72.25 $673,442
Option
Common Stock 12,500 $42.54 $531,750
Option
Common Stock 12,500 $42.54 $531,750
Sale
Common Stock 8,941 $73.55 $657,611
Sale
Common Stock 421 $59.76 $25,159
Sale
Common Stock 2,278 N/A N/A
Sale
Common Stock 1,222 N/A N/A
Sale
Common Stock 110 $60.81 $6,689
Sale
Common Stock 25,000 $31.34 $783,375
Option
Stock Option (Right to Buy) 25,000 N/A N/A
Option
Common Stock 25,000 $42.54 $1,063,500
Sale
Common Stock 25,420 $60.01 $1,525,327
Option
Common Stock 25,000 N/A N/A
Option
Stock Option (Right to Buy) 25,000 $42.54 $1,063,500

Pacira BioSciences key executives

Pacira BioSciences, Inc. executives and other stock owners filed with the SEC: